SILVER SPRING, Md., Feb. 26, 2021 /PRNewswire/ -- Following today's positive advisory committee meeting outcome regarding the Janssen Biotech Inc. COVID-19 Vaccine, the U.S. Food and Drug Administration has informed the sponsor that it will rapidly work toward finalization and issuance of...
from PR Newswire: https://ift.tt/3dRf6Fu
No comments:
Post a Comment